abstract |
This disclosure relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof: Formula (I), in which n, R 1 , R 1 ′, R 2 , R 3 , R 4 , R 4 ′, and R 5 -R 14 are defined in the specification. The compounds of formula (I) can be used to treat bacterial infection. |